These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25799902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Use and costs of concomitant medicines in epileptic patients in Poland: a 12-month prospective multicentre study.
    Majkowska-Zwolińska B, Jędrzejczak J, Majkowski J.
    Seizure; 2011 Nov; 20(9):673-8. PubMed ID: 21757378
    [Abstract] [Full Text] [Related]

  • 24. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY, Wu N, Boulanger L, Sacco P.
    J Med Econ; 2013 Nov; 16(2):240-8. PubMed ID: 23171361
    [Abstract] [Full Text] [Related]

  • 25. Uptake and costs of care for epilepsy: findings from a U.K. regional study.
    Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D.
    Epilepsia; 1998 Jul; 39(7):776-86. PubMed ID: 9670907
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prescribing antiepileptic drugs: should patients be switched on the basis of cost?
    Jobst BC, Holmes GL.
    CNS Drugs; 2004 Jul; 18(10):617-28. PubMed ID: 15270592
    [Abstract] [Full Text] [Related]

  • 28. Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.
    Italiano D, Capuano A, Alibrandi A, Ferrara R, Cannata A, Trifirò G, Sultana J, Ferrajolo C, Tari M, Tari DU, Perrotta M, Pagliaro C, Rafaniello C, Spina E, Arcoraci V.
    Br J Clin Pharmacol; 2015 Jun; 79(6):1010-9. PubMed ID: 25556909
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.
    Knoester PD, Deckers CL, Termeer EH, Boendermaker AJ, Kotsopoulos IA, de Krom MC, Keyser T, Renier WO, Hekster YA, Severens HL.
    Value Health; 2007 Jun; 10(3):173-82. PubMed ID: 17532810
    [Abstract] [Full Text] [Related]

  • 33. The direct medical costs of epilepsy in children and young people: a population-based study of health resource utilisation.
    Ali MA, Elliott RA, Tata LJ.
    Epilepsy Res; 2014 Mar; 108(3):576-86. PubMed ID: 24447611
    [Abstract] [Full Text] [Related]

  • 34. Health care costs decline after successful epilepsy surgery.
    Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S.
    Neurology; 2007 Apr 17; 68(16):1290-8. PubMed ID: 17438219
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F, Duh MS, Gosselin A, Paradis PE.
    Epilepsia; 2007 Mar 17; 48(3):464-9. PubMed ID: 17346246
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.